Bearish flow noted in AbbVie with 2,165 puts trading, or 1.3x expected. Most active are Sep-24 165 puts and Apr-24 180 puts, with total volume in those strikes near 530 contracts. The Put/Call Ratio is 1.55, while ATM IV is up over 1 point on the day. Earnings are expected on April 25th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- This Biopharma Stock Outperformed MSTR and SMCI in March 2024
- AbbVie price target raised to $195 from $185 at Barclays
- Fly Insider: NextNav, Akamai among week’s notable insider trades
- AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
- AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases